Fractyl Labs

formerly Fractyl HealthIPO

Transformative Metabolic Therapies

Public · Boston, United States · Founded 2011 · $339.0M raised

Employees
51–200
Founded
2011
Business Model
B2B
Total Funding
$339.0M
Last Round
$60.0M Venture RoundSep 2025
Rounds
7
Type
Public

About

Fractyl Health (formerly Fractyl Labs) is a clinical-stage metabolic therapeutics company developing breakthrough therapies targeting root causes of obesity and type 2 diabetes. Its lead platform, Revita, is an outpatient endoscopic procedure designed to resurface the duodenal lining. The company also develops Rejuva, a gene therapy platform targeting pancreatic islet cells for long-term metabolic disease remission.

Summary

Fractyl Labs is a Healthcare company based in Boston, United States, founded in 2011. It has raised $339.0M in total across 7 rounds, most recently a $60.0M Venture Round round in Sep 2025. Investors include Nantahala Capital, ADAR1 Capital and GV.

Tech & App Stack

4 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Venture RoundVenture RoundSep 2025
$60.0M

Sign up to see all 8 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies